Clinical Trials
3 trialsNCT01020539 2021-08-06
AML/MDS/JMML
Columbia University
Phase 1 Completed
NCT00669890 2015-04-22
High Risk
New York Medical College
Phase 1 Terminated
NCT00028899 2014-02-20
Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes
Children's Oncology Group
Phase 1 Completed